Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90


Novel modeling of cancer cell signaling pathways enables systematic drug repositioning for distinct breast cancer metastases.

Zhao H, Jin G, Cui K, Ren D, Liu T, Chen P, Wong S, Li F, Fan Y, Rodriguez A, Chang J, Wong ST.

Cancer Res. 2013 Oct 15;73(20):6149-63. doi: 10.1158/0008-5472.CAN-12-4617. Epub 2013 Oct 4.


Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, Heikkilä P, Joensuu H.

Breast Cancer Res. 2011 Sep 13;13(5):R87. doi: 10.1186/bcr2944.


Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.

Improta G, Zupa A, Fillmore H, Deng J, Aieta M, Musto P, Liotta LA, Broaddus W, Petricoin EF 3rd, Wulfkuhle JD.

J Proteome Res. 2011 Jul 1;10(7):3089-97. doi: 10.1021/pr200065t. Epub 2011 May 27.


Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.

Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A, Takigawa M.

J Bone Miner Res. 2006 Jul;21(7):1045-59.


Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.

Fang Y, Chen Y, Yu L, Zheng C, Qi Y, Li Z, Yang Z, Zhang Y, Shi T, Luo J, Liu M.

J Natl Cancer Inst. 2013 Jan 2;105(1):47-58. doi: 10.1093/jnci/djs485. Epub 2012 Nov 24.


Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.

Jung YY, Kim HM, Koo JS.

PLoS One. 2015 Sep 3;10(9):e0137204. doi: 10.1371/journal.pone.0137204. eCollection 2015.


Angiotensin II facilitates breast cancer cell migration and metastasis.

Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, Deshayes F, Pontes CL, Molina A, Cagnard N, Letourneur F, Morel M, Reis RI, Casarini DE, Terris B, Couraud PO, Costa-Neto CM, Di Benedetto M, Nahmias C.

PLoS One. 2012;7(4):e35667. doi: 10.1371/journal.pone.0035667. Epub 2012 Apr 20.


Distant metastasis in triple-negative breast cancer.

Tseng LM, Hsu NC, Chen SC, Lu YS, Lin CH, Chang DY, Li H, Lin YC, Chang HK, Chao TC, Ouyang F, Hou MF.

Neoplasma. 2013;60(3):290-4. doi: 10.4149/neo_2013_038.


The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.

Michigami T, Hiraga T, Williams PJ, Niewolna M, Nishimura R, Mundy GR, Yoneda T.

Breast Cancer Res Treat. 2002 Oct;75(3):249-58.


Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.

Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, Lidereau R, Driouch K.

J Natl Cancer Inst. 2011 Sep 7;103(17):1323-37. doi: 10.1093/jnci/djr290. Epub 2011 Aug 10.


A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.

Sanz-Pamplona R, García-García J, Franco S, Messeguer X, Driouch K, Oliva B, Sierra A.

Mol Biosyst. 2012 Aug;8(8):2085-96. doi: 10.1039/c2mb25104c. Epub 2012 Jun 18.


αv-Integrin isoform expression in primary human tumors and brain metastases.

Vogetseder A, Thies S, Ingold B, Roth P, Weller M, Schraml P, Goodman SL, Moch H.

Int J Cancer. 2013 Nov 15;133(10):2362-71. doi: 10.1002/ijc.28267. Epub 2013 Jun 10.


A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.

Jadamba E, Shin M.

Biomed Res Int. 2016;2016:7147039. doi: 10.1155/2016/7147039. Epub 2016 Dec 26.


Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.

Cha YJ, Kim DH, Jung WH, Koo JS.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7824-33. eCollection 2014.


A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy.

Jin G, Fu C, Zhao H, Cui K, Chang J, Wong ST.

Cancer Res. 2012 Jan 1;72(1):33-44. doi: 10.1158/0008-5472.CAN-11-2333. Epub 2011 Nov 22.


[A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].

Sueyoshi K, Ogura Y, Komori T, Takahashi M, Tian TX, Tatsumi T, Matsuki M, Saika Y, Uesugi Y, Utsunomiya K, Inomata Y, Narabayashi I.

Gan To Kagaku Ryoho. 2002 Oct;29(10):1795-9. Japanese.


Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

Dunn LK, Mohammad KS, Fournier PG, McKenna CR, Davis HW, Niewolna M, Peng XH, Chirgwin JM, Guise TA.

PLoS One. 2009 Sep 3;4(9):e6896. doi: 10.1371/journal.pone.0006896.


Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin.

Ihnen M, Kilic E, Köhler N, Löning T, Witzel I, Hagel C, Höller S, Kersten JF, Müller V, Jänicke F, Milde-Langosch K.

J Clin Pathol. 2011 Feb;64(2):146-52. doi: 10.1136/jcp.2010.082602.


Adaptation of energy metabolism in breast cancer brain metastases.

Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR 3rd, Felding-Habermann B.

Cancer Res. 2007 Feb 15;67(4):1472-86.


CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.

Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S.

J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512. doi: 10.1093/jnci/djq343. Epub 2010 Sep 17.

Supplemental Content

Support Center